Roughly a month ago, on the 11th of July, China’s National Medical Products Administration gave regulatory clearance for CSPC Pharmaceutical Group’s respiratory syncytial virus (RSV) vaccine (SYS6016) to conduct clinical trials in China. Do you know the significance of this vaccine for the newborns in China? Wonder how you can avoid paying vaccination expenses out-of-pocket? …